BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 142 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,021,470 | -20.5% | 438,500 | 0.0% | 0.40% | -15.4% |
| Q2 2023 | $27,713,200 | +40.5% | 438,500 | 0.0% | 0.47% | +29.3% |
| Q1 2023 | $19,728,115 | +2.7% | 438,500 | 0.0% | 0.36% | -4.5% |
| Q4 2022 | $19,210,685 | -33.5% | 438,500 | 0.0% | 0.38% | -33.3% |
| Q3 2022 | $28,893,000 | +30.4% | 438,500 | 0.0% | 0.57% | +19.8% |
| Q2 2022 | $22,149,000 | -41.5% | 438,500 | -26.0% | 0.47% | -20.1% |
| Q1 2022 | $37,849,000 | -10.7% | 592,500 | +49.7% | 0.59% | +9.4% |
| Q4 2021 | $42,394,000 | +15.8% | 395,800 | +11.2% | 0.54% | +12.2% |
| Q3 2021 | $36,600,000 | -9.9% | 356,000 | -22.9% | 0.48% | -11.5% |
| Q2 2021 | $40,612,000 | -9.6% | 461,712 | -0.1% | 0.55% | -18.0% |
| Q1 2021 | $44,920,000 | -13.3% | 462,000 | 0.0% | 0.67% | -16.2% |
| Q4 2020 | $51,813,000 | +21.0% | 462,000 | 0.0% | 0.80% | -5.1% |
| Q3 2020 | $42,827,000 | +18.8% | 462,000 | 0.0% | 0.84% | +7.0% |
| Q2 2020 | $36,036,000 | +33.4% | 462,000 | 0.0% | 0.78% | -10.5% |
| Q1 2020 | $27,018,000 | -27.0% | 462,000 | 0.0% | 0.88% | -16.1% |
| Q4 2019 | $37,011,000 | +9.0% | 462,000 | 0.0% | 1.04% | -7.0% |
| Q3 2019 | $33,943,000 | -22.1% | 462,000 | 0.0% | 1.12% | -15.3% |
| Q2 2019 | $43,580,000 | +17.8% | 462,000 | 0.0% | 1.32% | +4.1% |
| Q1 2019 | $36,983,000 | +66.5% | 462,000 | +12.1% | 1.27% | +29.5% |
| Q4 2018 | $22,211,000 | +0.9% | 412,000 | +46.1% | 0.98% | +21.7% |
| Q3 2018 | $22,013,000 | +131.2% | 282,000 | +88.0% | 0.81% | +104.6% |
| Q2 2018 | $9,522,000 | -30.8% | 150,000 | 0.0% | 0.40% | -38.7% |
| Q1 2018 | $13,755,000 | +21.6% | 150,000 | 0.0% | 0.64% | +9.2% |
| Q4 2017 | $11,312,000 | -31.2% | 150,000 | -36.4% | 0.59% | -36.7% |
| Q3 2017 | $16,442,000 | +22.4% | 236,000 | -10.9% | 0.93% | +11.5% |
| Q2 2017 | $13,428,000 | +26.7% | 265,000 | 0.0% | 0.84% | +19.1% |
| Q1 2017 | $10,597,000 | +42.6% | 265,000 | 0.0% | 0.70% | +45.0% |
| Q4 2016 | $7,433,000 | -5.6% | 265,000 | 0.0% | 0.48% | +0.6% |
| Q3 2016 | $7,871,000 | +46.7% | 265,000 | 0.0% | 0.48% | +46.6% |
| Q2 2016 | $5,366,000 | +20.6% | 265,000 | +7.5% | 0.33% | +31.7% |
| Q1 2016 | $4,449,000 | -31.5% | 246,500 | 0.0% | 0.25% | -23.4% |
| Q4 2015 | $6,493,000 | +184.4% | 246,500 | +130.4% | 0.32% | +144.4% |
| Q3 2015 | $2,283,000 | – | 107,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |